Journal profile · Biotechnology & Applied Microbiology
Biopharm international
ISSN 1542-166X · eISSN 1939-1862 · Advanstar Communications Inc. · UNITED STATES · Monthly · Founded 2002
Biopharm international: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.06; subscription journal; review 6–12 weeks (community reports); community-reported acceptance: easy; 5 articles a year; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biopharm international is published by Advanstar Communications Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects, together about 31.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
BioPharm International integrates the science and business of biopharmaceuticals, covering all aspects of biopharmaceutical research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging, as well as business strategies and regulatory issues.
Source: LetPub
Research area (LetPub): Biotechnology & Applied Microbiology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology14.3%
- Monoclonal and Polyclonal Antibodies ResearchMedicine8.6%
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology8.6%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology5.7%
- Viral Infections and Outbreaks ResearchMedicine5.7%
- Mosquito-borne diseases and controlMedicine2.9%
- IoT and Edge/Fog ComputingComputer Science2.9%
- Hepatitis B Virus StudiesMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.06LetPub ·
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.04LetPub ·
- h-index
- 25LetPub ·
- h-index
- 7OpenAlex ·
- i10-index
- 7OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 5LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Advanstar Communications Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2002
- ISSN
- 1542-166X
- Electronic ISSN
- 1939-1862
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Biopharm international
What CAS zone is Biopharm international in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biopharm international is in Zone 4 of Medicine, and in Zone 4 of the minor category Biotechnology & Applied Microbiology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biopharm international?
The latest impact factor listed by LetPub is 0.06; CiteScore 0.4, h-index 7.
How long does peer review take at Biopharm international?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biopharm international?
According to LetPub and DOAJ records, Biopharm international is indexed in SCIE and Scopus.
Is Biopharm international open access, and what is the APC?
Biopharm international is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .